Navigation Links
Haemolance Plus Safety Lancets

ProductsHaemolance Plus Safety Lancets
Company ARKRAY USA
Item Haemolance Plus Safety Lancets
Features 
  • Needle retracts automatically and locks out for extra safety
  • Quick spring action for patient comfort
  • Designed to help facilities meet OSHA requirements for needlestick safety
  • Ergonomic and easy to handle
Description Haemolance Plus Safety Lancets help protect healthcare professionals and patients from accidental needle stick injuries and cross-contamination. Designed to help facilities meet OSHA requirements for needlestick safety, the needle is shielded prior to and after use. The Haemolance Plus features automatic lockout after use. Its rapid needle retraction promotes patient comfort. Needle depth control offers consistent sampling results. Haemolance Plus Safety Lancets are available in 28, 25, 21, and 18 gauge formats and 1.2 & 1.6 blade depth formats.
Info ARKRAY USA
Customer Service: 952-646-3200
Web site: http://www.arkrayusa.com/home.html

Related medicine products :

1. The Haemolance Safety Lancets
2. Safety Lock Rib-Back
3. Bunnell Mini-Modified Safety Finger Pin
4. Class II Type A2 Biological Safety Cabinet
5. Class II Type B1 Biological Safety Cabinet
6. Calss II Type B2 Biological Safety Cabinet
7. Class II Type B2 Biological Safety Cabinet
8. Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
9. Fixed Core Straight Safety Wire Guides - Standard (PTFE coated)
10. Fixed Core Straight Safety Wire Guides - Standard (stainless steel SlipCoat®)
11. Fixed Core Straight Safety Wire Guides - Newton Cerebral (stainless steel SlipCoat®)
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 1GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 2GenVec Announces Registered Offering of 246 Million in Common Stock and Warrants 13717 3Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24 2009 13716 1Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 1Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 2